[Federal Register: August 6, 1998 (Volume 63, Number 151)]
[Notices]               
[Page 42065]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au98-87]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated May 7, 1998, and published in the Federal Register 
on May 19, 1998 (63 FR 27590), Roche Diagnostic Systems, Inc., 1080 
U.S. Highway 202, Somerville, New Jersey 08876-3771), made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of tetrahydrocannabinols (7370), a basic 
class of controlled substance listed in Schedule I.
    The tetrahydrocannabinols will be utilized exclusively for non-
human consumption in drug of abuse detection kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Roche Diagnostic Systems to import 
tetrahydrocannabinols is consistent with the public interest and with 
United Sates obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. Therefore, pursuant 
to Section 1008(a) of the Controlled Substances Import and Export Act 
and in accordance with Title 21, Code of Federal Regulations, Section 
1301.34, the above firm is granted registration as an importer of the 
basic class of controlled substance listed above.

    Dated: July 17, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-20974 Filed 8-5-98; 8:45 am]
BILLING CODE 4410-09-M